-
Most Popular
![Healthcare Stocks Icon](https://investorplace.com/wp-content/uploads/2022/12/healthcare-150x150.png)
Healthcare Stocks
Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.
![The words "recession proof" written on a pink sticky note. bulletproof stocks](https://investorplace.com/wp-content/uploads/2023/07/shutterstock_2170602547-150x150.jpg)
7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.
![Interest rate and dividend concept. Businessman with percentage symbol and up arrow, Interest rates continue to increase, return on stocks and mutual funds, long term investment for retirement. Dividend stocks](https://investorplace.com/wp-content/uploads/2024/06/dividend-stocks1600-5-150x150.png)
7 Dependable Dividend Stocks for Long-Term Income
Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.
![medicine research, pharmaceutical background, LJPC stock](https://investorplace.com/wp-content/uploads/2022/03/pharmaceuticals_tnxp_1600-150x150.png)
3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct
These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.
Recent Healthcare Stocks Articles
Why Is Clearmind Medicine (CMND) Stock Up 50% Today?
Psychedelic-medicine specialist Clearmind Medicine posted encouraging study results, leading to a significant boost in CMND stock.
Why Is Replimune (REPL) Stock Down 48% Today?
Replimune stock is dropping on Tuesday as investors in REPL shares react to a clinical trial missing both of its primary endpoints.
Why Is Allarity Therapeutics (ALLR) Stock Up 42% Today?
Allarity Therapeutics stock is rising higher on Tuesday with heavy trading of ALLR stock alongside early clinical trial data.
Why Is iBio (IBIO) Stock Down 41% Today?
Ibio stock is falling on Tuesday after the biotechnology company announced the pricing of its shares in a public offering.
Wealth Accumulation: 3 Stocks with Multibagger Potential
After fears pushed many stocks with great potential to very low levels, it's a great time to buy names that could become multibagger stocks.
Why Is Alterity Therapeutics (ATHE) Stock Up 150% Today?
Although Alterity Therapeutics revealed encouraging data with its PD therapeutic candidate, ATHE stock still faces challenges.
Why Is EyePoint Pharmaceuticals (EYPT) Stock Up 187% Today?
EyePoint Pharmaceuticals stock is rising higher with heavy trading of EYPT on Monday after posting positive results from a clinical trial.
Why Is NLS Pharmaceutics (NLSP) Stock Down 24% Today?
NLS Pharmaceutics stock is falling on Monday after shares of NLSP stock underwent a strong rally with heavy trading on Friday.
Why Is Altimmune (ALT) Stock Up 43% Today?
Altimmune stock is rising higher on Friday with heavy trading of ALT shares after posting positive results form a clinical trial.
Pfizer Layoffs 2023: What to Know About the Latest PFE Job Cuts
Pfizer layoffs are on the way for workers at the company's Groton, Conn. facility as it seeks to reduce costs by cutting jobs.
Why Is NexImmune (NEXI) Stock Up 353% Today?
NexImmune stock is seeing massive gains on Friday with heavy trading of NEXI shares despite a lack of news from the biotechnology company.
Billionaire Favorites: 3 Ultra-High Yield Stocks the Elite Love
Buying stocks simple for their high dividend yields is risky but these are three stocks the elite love regardless.